Mylan personnel appointments
Executive Summary
VP-Generic Business Development John Deiriggi is appointed to the new position of chief operating officer of Mylan's generic subsidiary, Mylan Pharmaceuticals, the company announces. Deiriggi is a 19-year veteran of Mylan. In connection with the promotion, Exec Director of Corporate Administration Daniel Caron will take over as VP of generic business development. Additional moves include Gary Sphar to the post of exec VP and CFO of Mylan Pharmaceuticals and Brian Roman to the post of VP and general counsel of the generic subsidiary...